ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features

Comparison with conventional prostatic adenocarcinoma

Hunter Johnson, Ming Zhou, Adeboye O. Osunkoya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Summary TMPRSS2-ERG is the most common gene fusion in conventional prostatic adenocarcinoma (PCa), identified in about 40% to 70% of cases. Mucinous PCa and PCa with mucinous features are rare subtypes of prostate cancer, and ERG expression in these subtypes has not been well characterized in a large series. A search was made through the surgical pathology and expert consultation files of 2 major academic institutions for cases of mucinous PCa and PCa with mucinous features. The former were obtained from radical prostatectomy cases and the latter from radical prostatectomy cases, transurethral resection of the prostate, and prostate needle core biopsies. A tissue microarray composed of additional cases of mucinous PCa was also included in the study. Immunohistochemical stains for ERG were performed on all the cases. A total of 51 cases of mucinous PCa and PCa with mucinous features were identified. Twenty-five of 51 (47%) cases were positive for ERG expression, including 10/24 (42%) radical prostatectomy specimens, 7/14 (50%) biopsies, 2/4 (50%) transurethral resection of the prostate specimens, 6/9 (67%) from a tissue microarray. This is the largest study to date specifically characterizing ERG expression in mucinous PCa and PCa with mucinous features, with emphasis on comparison with adjacent conventional PCa. ERG is expressed in almost 50% of cases of mucinous PCa and PCa with mucinous features, similar to rates of expression in conventional PCa. This study strongly suggests that these rare subtypes of PCa are clonally related to conventional PCa.

Original languageEnglish (US)
Pages (from-to)2241-2246
Number of pages6
JournalHuman Pathology
Volume44
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Mucinous Adenocarcinoma
Adenocarcinoma
Prostatectomy
Transurethral Resection of Prostate
Large-Core Needle Biopsy
Surgical Pathology
Gene Fusion
Prostate
Prostatic Neoplasms
Coloring Agents
Referral and Consultation

Keywords

  • Conventional prostatic adenocarcinoma
  • ERG antibody
  • Mucinous prostatic adenocarcinoma
  • Prostatic adenocarcinoma with mucinous features
  • TMPRSS2-ERG

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features : Comparison with conventional prostatic adenocarcinoma. / Johnson, Hunter; Zhou, Ming; Osunkoya, Adeboye O.

In: Human Pathology, Vol. 44, No. 10, 01.10.2013, p. 2241-2246.

Research output: Contribution to journalArticle

@article{92919638291f4798b50c02af9df33047,
title = "ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: Comparison with conventional prostatic adenocarcinoma",
abstract = "Summary TMPRSS2-ERG is the most common gene fusion in conventional prostatic adenocarcinoma (PCa), identified in about 40{\%} to 70{\%} of cases. Mucinous PCa and PCa with mucinous features are rare subtypes of prostate cancer, and ERG expression in these subtypes has not been well characterized in a large series. A search was made through the surgical pathology and expert consultation files of 2 major academic institutions for cases of mucinous PCa and PCa with mucinous features. The former were obtained from radical prostatectomy cases and the latter from radical prostatectomy cases, transurethral resection of the prostate, and prostate needle core biopsies. A tissue microarray composed of additional cases of mucinous PCa was also included in the study. Immunohistochemical stains for ERG were performed on all the cases. A total of 51 cases of mucinous PCa and PCa with mucinous features were identified. Twenty-five of 51 (47{\%}) cases were positive for ERG expression, including 10/24 (42{\%}) radical prostatectomy specimens, 7/14 (50{\%}) biopsies, 2/4 (50{\%}) transurethral resection of the prostate specimens, 6/9 (67{\%}) from a tissue microarray. This is the largest study to date specifically characterizing ERG expression in mucinous PCa and PCa with mucinous features, with emphasis on comparison with adjacent conventional PCa. ERG is expressed in almost 50{\%} of cases of mucinous PCa and PCa with mucinous features, similar to rates of expression in conventional PCa. This study strongly suggests that these rare subtypes of PCa are clonally related to conventional PCa.",
keywords = "Conventional prostatic adenocarcinoma, ERG antibody, Mucinous prostatic adenocarcinoma, Prostatic adenocarcinoma with mucinous features, TMPRSS2-ERG",
author = "Hunter Johnson and Ming Zhou and Osunkoya, {Adeboye O.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.humpath.2013.05.006",
language = "English (US)",
volume = "44",
pages = "2241--2246",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features

T2 - Comparison with conventional prostatic adenocarcinoma

AU - Johnson, Hunter

AU - Zhou, Ming

AU - Osunkoya, Adeboye O.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Summary TMPRSS2-ERG is the most common gene fusion in conventional prostatic adenocarcinoma (PCa), identified in about 40% to 70% of cases. Mucinous PCa and PCa with mucinous features are rare subtypes of prostate cancer, and ERG expression in these subtypes has not been well characterized in a large series. A search was made through the surgical pathology and expert consultation files of 2 major academic institutions for cases of mucinous PCa and PCa with mucinous features. The former were obtained from radical prostatectomy cases and the latter from radical prostatectomy cases, transurethral resection of the prostate, and prostate needle core biopsies. A tissue microarray composed of additional cases of mucinous PCa was also included in the study. Immunohistochemical stains for ERG were performed on all the cases. A total of 51 cases of mucinous PCa and PCa with mucinous features were identified. Twenty-five of 51 (47%) cases were positive for ERG expression, including 10/24 (42%) radical prostatectomy specimens, 7/14 (50%) biopsies, 2/4 (50%) transurethral resection of the prostate specimens, 6/9 (67%) from a tissue microarray. This is the largest study to date specifically characterizing ERG expression in mucinous PCa and PCa with mucinous features, with emphasis on comparison with adjacent conventional PCa. ERG is expressed in almost 50% of cases of mucinous PCa and PCa with mucinous features, similar to rates of expression in conventional PCa. This study strongly suggests that these rare subtypes of PCa are clonally related to conventional PCa.

AB - Summary TMPRSS2-ERG is the most common gene fusion in conventional prostatic adenocarcinoma (PCa), identified in about 40% to 70% of cases. Mucinous PCa and PCa with mucinous features are rare subtypes of prostate cancer, and ERG expression in these subtypes has not been well characterized in a large series. A search was made through the surgical pathology and expert consultation files of 2 major academic institutions for cases of mucinous PCa and PCa with mucinous features. The former were obtained from radical prostatectomy cases and the latter from radical prostatectomy cases, transurethral resection of the prostate, and prostate needle core biopsies. A tissue microarray composed of additional cases of mucinous PCa was also included in the study. Immunohistochemical stains for ERG were performed on all the cases. A total of 51 cases of mucinous PCa and PCa with mucinous features were identified. Twenty-five of 51 (47%) cases were positive for ERG expression, including 10/24 (42%) radical prostatectomy specimens, 7/14 (50%) biopsies, 2/4 (50%) transurethral resection of the prostate specimens, 6/9 (67%) from a tissue microarray. This is the largest study to date specifically characterizing ERG expression in mucinous PCa and PCa with mucinous features, with emphasis on comparison with adjacent conventional PCa. ERG is expressed in almost 50% of cases of mucinous PCa and PCa with mucinous features, similar to rates of expression in conventional PCa. This study strongly suggests that these rare subtypes of PCa are clonally related to conventional PCa.

KW - Conventional prostatic adenocarcinoma

KW - ERG antibody

KW - Mucinous prostatic adenocarcinoma

KW - Prostatic adenocarcinoma with mucinous features

KW - TMPRSS2-ERG

UR - http://www.scopus.com/inward/record.url?scp=84884413273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884413273&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2013.05.006

DO - 10.1016/j.humpath.2013.05.006

M3 - Article

VL - 44

SP - 2241

EP - 2246

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 10

ER -